Literature DB >> 8326007

Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.

H Ito1, Y Hirata, S Adachi, M Tanaka, M Tsujino, A Koike, A Nogami, F Murumo, M Hiroe.   

Abstract

To elucidate the cellular mechanism by which angiotensin II (ANG II) induces cardiac hypertrophy, we investigated the possible autocrine/paracrine role of endogenous endothelin-1 (ET-1) in ANG II-induced hypertrophy of neonatal rat cardiomyocytes by use of synthetic ET-1 receptor antagonist and antisense oligonucleotides to preproET-1 (ppET-1) mRNA. Northern blot analysis and in situ hybridization revealed that ppET-1 mRNA was expressed in cardiomyocytes, but, to a lesser extent, in nonmyocytes as well. ANG II upregulated ppET-1 mRNA level by threefold over control level as early as 30 min, and it stimulated release of immunoreactive ET-1 from cardiomyocytes in a dose- and time-dependent manner. ET-1 stimulated ppET-1 mRNA levels after 30 min in a similar fashion as ANG II. Tetradecanoylphorbol-acetate (10(-7) M) mimicked the effects of ANG II and ET-1 on induction of ppET-1 mRNA. ANG II-induced ppET-1 gene expression was completely blocked by protein kinase C inhibitor H-7 or by down-regulation of endogenous protein kinase C by pretreatment with phorbol ester. ET-1 and ANG II stimulated twofold increase [3H]leucine incorporation into cardiomyocytes, whose effects were similarly and dose dependently inhibited by endothelin A receptor antagonist (BQ123). Introduction of antisense sequence against coding region of ppET-1 mRNA into cardiomyocytes resulted in complete blockade with ppET-1 mRNA levels and [3H]leucine incorporation stimulated by ANG II. These results suggest that endogenous ET-1 locally generated and secreted by cardiomyocytes may contribute to ANG II-induced cardiac hypertrophy via an autocrine/paracrine fashion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8326007      PMCID: PMC293624          DOI: 10.1172/JCI116579

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.

Authors:  T Imai; Y Hirata; T Emori; M Yanagisawa; T Masaki; F Marumo
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

2.  Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells.

Authors:  Y Hirata; H Yoshimi; S Takaichi; M Yanagisawa; T Masaki
Journal:  FEBS Lett       Date:  1988-10-24       Impact factor: 4.124

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol.

Authors:  P Simpson; S Savion
Journal:  Circ Res       Date:  1982-01       Impact factor: 17.367

6.  The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression.

Authors:  A Inoue; M Yanagisawa; Y Takuwa; Y Mitsui; M Kobayashi; T Masaki
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

7.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.

Authors:  W Lee; P Mitchell; R Tjian
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

8.  Concomitant secretion of big endothelin and its C-terminal fragment from human and bovine endothelial cells.

Authors:  T Emori; Y Hirata; K Ohta; M Shichiri; K Shimokado; F Marumo
Journal:  Biochem Biophys Res Commun       Date:  1989-07-14       Impact factor: 3.575

Review 9.  Fos-associated protein p39 is the product of the jun proto-oncogene.

Authors:  F J Rauscher; D R Cohen; T Curran; T J Bos; P K Vogt; D Bohmann; R Tjian; B R Franza
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  78 in total

1.  Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.

Authors:  J Kyselovic; P Krenek; M Wibo; T Godfraind
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 2.  Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.

Authors:  Shikha Mishra; Haiyun Ling; Michael Grimm; Tong Zhang; Don M Bers; Joan Heller Brown
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

3.  Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts.

Authors:  C Ruwhof; A E van Wamel; J M Egas; A van der Laarse
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

Review 4.  Endothelin antagonism in experimental ischemic heart failure: hemodynamic, structural and neurohumoral effects.

Authors:  P Mulder; V Richard; C Thuillez
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

5.  Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung.

Authors:  L Zhao; R al-Tubuly; A Sebkhi; A A Owji; D J Nunez; M R Wilkins
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

6.  Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1.

Authors:  María V Correa; Mariela B Nolly; Claudia I Caldiz; Gladys E Chiappe de Cingolani; Horacio E Cingolani; Irene L Ennis
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

7.  Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy.

Authors:  Asli F Ceylan-Isik; Maolong Dong; Yingmei Zhang; Feng Dong; Subat Turdi; Sreejayan Nair; Masashi Yanagisawa; Jun Ren
Journal:  Basic Res Cardiol       Date:  2013-02-05       Impact factor: 17.165

8.  Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan.

Authors:  M Turcani; H Rupp
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

9.  Original Research: Atorvastatin prevents rat cardiomyocyte hypertrophy induced by parathyroid hormone 1-34 associated with the Ras-ERK signaling.

Authors:  Xiaogang Liu; Chunbo Zou; Chengyuan Yu; Rujuan Xie; Manshu Sui; Suhong Mu; Li Li; Shilei Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

10.  Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium.

Authors:  Claudia I Caldiz; Carolina D Garciarena; Raúl A Dulce; Leonardo P Novaretto; Alejandra M Yeves; Irene L Ennis; Horacio E Cingolani; Gladys Chiappe de Cingolani; Néstor G Pérez
Journal:  J Physiol       Date:  2007-09-06       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.